News & Perspective

Oct 04, 2006

Oct 04, 2006

Groups call for pandemic flu vaccine 'master plan'

(CIDRAP News) – Public health and infectious disease experts today called on the United States to develop a "master plan" for development of pandemic influenza vaccines in order to translate scientific advances more rapidly into improved pandemic preparedness.

Sep 08, 2006

Sep 08, 2006

Could blood from H5N1 flu survivors help others?

(CIDRAP News) – A recent report about the use of blood products to treat patients in the Spanish influenza pandemic of 1918 has sparked interest among those concerned about the threat of the next pandemic, but experts say it's far from clear whether the approach would be practicable in a pandemic today.

Aug 18, 2006

Aug 18, 2006

WHO changes H5N1 strains for pandemic vaccines, raising concern over virus evolution

(CIDRAP News) – The World Health Organization (WHO) today changed the H5N1 avian influenza strains recommended for candidate vaccines for the first time since 2004, causing some experts to question how far the virus has evolved.

The WHO's new prototype strains, prepared by reverse genetics, include three new H5N1 subclades.

May 24, 2006

May 24, 2006

Two generations of spread possible in Indonesia H5N1 cases

(CIDRAP News) – For the first time, evidence suggests that the H5N1 avian influenza virus may have passed from one person to another and on to a third, according to a World Health Organization (WHO) official.

Referring to the extended-family case cluster in Indonesia, the WHO's Maria Cheng told the Canadian Press (CP) yesterday, "This is the first time we have seen cases that have gone beyond one generation of human-to-human spread."

Apr 11, 2006

Apr 11, 2006

Would an imperfect vaccine be useful in a flu pandemic?

(CIDRAP News) – A mathematical modeling study suggests that a modestly effective vaccine could keep an influenza pandemic from striking more than 10% of the US population, but only if large amounts of vaccine were distributed quickly and the virus was not too highly contagious.

Mar 30, 2006

Mar 30, 2006

H5N1 vaccine trial shows limited benefit

(CIDRAP News) – The first experimental US vaccine for H5N1 avian influenza yielded only modest results in its first clinical trial, generating an adequate immune response in slightly more than half of participants who received a heavy dose, scientists report.

Mar 22, 2006

Mar 22, 2006

WHO issues revised plan to douse pandemic spark

(CIDRAP News) – The World Health Organization (WHO) has published a new draft of its plan for spotting and stopping a budding influenza pandemic.

Mar 07, 2006

Mar 07, 2006

HHS using Indonesian strain for second H5N1 flu vaccine

(CIDRAP News) – A second vaccine against human H5N1 influenza is being developed, US Health and Human Services (HHS) Secretary Mike Leavitt announced yesterday.

In a speech at an immunization conference, Leavitt announced that he has authorized the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to start work on a second vaccine, according to an Associated Press (AP) report published yesterday.

Feb 17, 2006

Feb 17, 2006

2006 SUMMIT COVERAGE: Businesses zero in on details of pandemic flu planning

(CIDRAP News) – Critical for businesses in preparing for a flu pandemic will be taking care of their primary asset—their employees. This was an overarching theme expressed by participants in this week's Business Planning for Pandemic Influenza: A National Summit, held in Minneapolis.

Feb 15, 2006

Feb 15, 2006

2006 SUMMIT COVERAGE: Conference poll: 18% of businesses have pandemic plan

(CIDRAP News) – A large majority of about 300 business officials at a conference in Minneapolis believe that an influenza pandemic would significantly affect their business, but only 18% of the companies have completed a preparedness plan, according to a poll taken yesterday.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»